G6PD and phenylketonuria: In China, screening for IEM focuses on diseases such as phenylketonuria (PKU) and congenital hypothyroidism (CH), while other regions screen for glucose-6-phosphate dehydrogenase (G6PD) deficiency, depending on the disease.